Levomecor Inc.
Clinical trials sponsored by Levomecor Inc., explained in plain language.
-
Depression drug trial halted mid-study
Symptom relief TerminatedThis study tested whether adding a daily pill called REL-1017 to a person's usual antidepressant could better relieve major depression symptoms. About 236 adults with depression that wasn't fully controlled by their current medication took either REL-1017 or a placebo. The trial …
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
New depression pill shows promise in early trial
Symptom relief TerminatedThis study tested a new drug called REL-1017 as an add-on treatment for adults with major depression who did not get enough help from standard antidepressants. The trial was stopped early after enrolling only 27 participants. The main goal was to measure changes in depression sym…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC